Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Diatos licenses European rights for Super-Leu-Dox

April 24, 2003

Novel modulators of LPA receptors and their use in cancer, wound healing, etc.

April 24, 2003

Aventis scientists identify novel protein kinase inhibitors

April 24, 2003

Novel tyrosine kinase inhibitors under study at Merck & Co.

April 24, 2003

Three series of antitumor agents prepared and tested at Synta

April 24, 2003

AGI Dermatics regains rights to Dimericine

April 23, 2003

Phase II studies of ILX-651 planned

April 23, 2003

Northwest Biotherapeutics receives NCI grant for tumor growth inhibition

April 23, 2003

Vitamin E analogue sensitizes Jurkat cells by suppressing NF-kB activation

April 23, 2003

Benzimidazole CDK4 inhibitors under study at Aventis

April 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...